Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00050128 · ClinicalTrials.gov registry record · Phase 1
Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation
A Phase 1 study of Cerebrovascular Accident, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00050128 is a Phase 1 study of Cerebrovascular Accident that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 15 participants, below the 517-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00050128, a Phase 1 study of Cerebrovascular Accident, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a preliminary study to evaluate the possible use of transcranial magnetic stimulation (TMS), together with exercise, for rehabilitation of chronic stroke patients. It will identify the optimum stimulation settings (within the limits of current safety guidelines) to be used in a later rehabilitation study and confirm the safety of the procedure at these settings. Some previous studies using TMS to treat movement disorders such as Parkinson's disease have shown improvement in motor function; others have not. The results of this study may provide information to help researchers design better rehabilitation treatments after stroke. Stroke patients with residual arm function and no history of seizures may be eligible for this study. The stroke must have occurred at least 6 months before entry into the study and must have affected only one side of the brain. For the TMS procedure, subjects are seated in a comfortable chair with their hands placed on a pillow on their lap. An insulated wire coil is placed on the scalp. A brief electrical current is passed through the coil, creating a magnetic pulse that stimulates the outer part of the brain, called the cortex. This may cause muscle, hand or arm twitching if the coil is near the part of the brain that controls movement, or it may affect movements or reflexes. Subjects are asked to make movements, do simple tasks, or tense muscles. Metal electrodes are taped to the skin over the muscle for computer recording of the electrical activity of the hand and arm muscles activated by the stimulation. The testing lasts 2-3 hours.
Conditions Studied
Interventions
- DEVICE rTMS, Magstim
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2002-11-18 |
| Est. Completion | 2007-10-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00050128
The ClinicalTrials.gov registry entry for NCT00050128 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 517-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (97% lower). The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cerebrovascular Accident appearing as the primary indexed condition, and to 1 intervention - of which rTMS, Magstim is the first listed.
NCT00050128 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00050128 about?
NCT00050128 is a clinical study titled "Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation". This is a preliminary study to evaluate the possible use of transcranial magnetic stimulation (TMS), together with exercise, for rehabilitation of chronic stroke patients. It will identify the optimum stimulation settings (within the limits of current safety guidelines) to be used in a later rehabil...
What is the current status of trial NCT00050128?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2002-11-18. Estimated completion is 2007-10-24.
What conditions does trial NCT00050128 study?
This clinical trial studies the following conditions: Cerebrovascular Accident.
What interventions are being tested in trial NCT00050128?
The interventions under investigation include: rTMS, Magstim (DEVICE).
Who is sponsoring clinical trial NCT00050128?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00050128 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebrovascular Accident
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Outcomes Associated With Progressive Balance And Gait Training Using The KineAssist® Robot
COMPLETED · Phase 1
-
Potential Risk Factors for Stroke
COMPLETED · Phase 1
-
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
RECRUITING · NA
-
Natural History of Stroke: Cause and Development
RECRUITING
-
Nomad P-KAFO Study
RECRUITING · NA
-
Achieving Meaningful Clinical Benchmarks With Ekso Gait Training During Acute Stroke Inpatient Rehabilitation.
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.